InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Fox Allan M., Director. Officer active across 1 companies, notably REGENXBIO Inc.. Aggregated, 5 disclosures have been published. Total volume traded: €7.4m. The latest transaction was disclosed on 3 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
03,010 shares0
Common Stock
SEC:0001562180-22-004875:0·
€2m61,638 shares@ €30.479350.4% of flow
Common Stock
SEC:0001562180-21-007876·
€2m61,638 shares@ €30.47930.64% mcap25.2% of flow
Common Stock
SEC:0001562180-21-007876:0·
€2m48,233 shares@ €38.273449.6% of flow
Common Stock
SEC:0000899243-21-036773·
€2m48,233 shares@ €38.27340.62% mcap24.8% of flow
Common Stock
SEC:0000899243-21-036773:0·
5 of 5 declarations
About Fox Allan M.
Allan M. Fox serves as a Director at REGENXBIO Inc. In this role, he participates in the governance of the company and strategic decision-making. Allan brings significant experience in the biopharmaceutical sector, enabling him to contribute to discussions on the direction and performance of the company. His expertise helps REGENXBIO achieve its growth objectives.
